As part of Beijing’s $40 billion Silk Road Fund, created for the implementation of Beijing’s “One Belt, One Road” policy aiming to improve economic cooperation and markets between China and the rest of Eurasia, China has announced plans to invest $1.9 billion in Kazakhstan’s agriculture industry. Although Kazakhstan is eighth among the top 10 wheat […]
At the 2016 China Healthcare Investment Conference, held in Shanghai in late March, the Chinese government emphasized the need for foreign investments and innovation in the pharmaceutical industry as part of China’s 13th five-year plan (2015–2010). Factors to aid Chinese innovation include in-licensing of pharmaceutical drugs, using US business locations to endorse high-class drugs in […]
According to a report entitled “International Comparative Performance of India’s Research Base (2009–2014)” released in February 2016, India’s research publication output has increased greatly since 2009, growing from 3.1% to 4.4% of the world’s total science research publication output in 2013, which equals a CAGR of 13.9%. In 2013, India released 106,065 papers, a 68.5% […]
IBO’s first report of 2016 for new laboratories outlines the construction and opening of labs in various sectors, including government, academia and biotechnology. On page 4, a table detailing the establishment of selected labs can be found, including new labs in the pharmaceutical industry. Government Various countries in Asia have broken ground on or approved […]
Currency fluctuations and economic turbulence not only produced a shift among IBO’s 2015 list of the top 30 analytical and life science instrument, aftermarket and lab product companies, but also yielded a calendar year sales decline when translated into US dollars. Total sales for the top 30 companies (see page 6) as reported in US […]
US equity markets steadily advanced in March with the Dow Jones Industrial Average, S&P 500 and NASDAQ improving 7.1%, 6.6% and 6.8%, respectively. Investors reacted favorably to US Federal Reserve Chair Janet Yellen’s dovish stance, as she advocated a more cautious approach to policy changes due to the fragile global economic environment. Consequently, the US […]
Science and technology are major sectors of investment for China’s next five-year plan, according to Chinese Premier Li Keqiang. China’s 13th five year plan from 2016 to 2020 will include a 9.1% increase to ¥271 billion ($41 billion) for science funding, as well as a focus on environmental sustainability and a cutting back on bureaucratic […]
On January 26, the National Health and Family Planning Commission of the People’s Republic of China issued the “Notice of Health and Family Planning Working Essentials for 2016,” which enables private investments in the life sciences industry. In accordance with the notice, the government of China plans to make improvements to the country’s health care […]
GenomeAsia 100K, a nonprofit organization dedicated to producing genomic data for Asian populations for genetic research and discovery, recently announced its plan to sequence 100,000 genomes. Initially, the project will study genomic data of 12 South Asian countries and a minimum of 7 North and East Asian countries. The first phase of the initiative will […]
The world’s 7th largest economy in 2014 and expected to become the 5th largest by 2018, Southeast Asia is a focus of global economic growth and opportunity due to an expanding middle class, increasing exports and the enactment last year of two trade pacts, the Trans-Pacific Partnership (TPP) and the ASEAN Economic Community (AEC). Of […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
